Granite Investment Partners’s AbbVie ABBV Stock Holding History

Granite Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Buy	47,914 +1,008	+2%	+$224K	0.64%	48
2025 Q4	$10.7M	Buy	46,906 +9,917	+27%	+$2.26M	0.64%	52
2025 Q3	$8.56M	Sell	36,989 -10,334	-22%	-$2.1M	0.49%	79
2025 Q2	$8.78M	Sell	47,323 -83	-0.2%	-$15.4K	0.43%	81
2025 Q1	$9.93M	Sell	47,406 -30	-0.1%	-$5.83K	0.5%	73
2024 Q4	$8.43M	Sell	47,436 -43,029	-48%	-$7.91M	0.36%	90
2024 Q3	$17.9M	Sell	90,465 -378	-0.4%	-$70.5K	0.76%	39
2024 Q2	$15.6M	Sell	90,843 -2,028	-2%	-$336K	0.65%	53
2024 Q1	$16.9M	Sell	92,871 -2,165	-2%	-$373K	0.64%	58
2023 Q4	$14.7M	Sell	95,036 -1,221	-1%	-$178K	0.57%	64
2023 Q3	$14.3M	Buy	96,257 +1,181	+1%	+$173K	0.6%	62
2023 Q2	$12.8M	Buy	95,076 +14,333	+18%	+$2.1M	0.51%	77
2023 Q1	$12.9M	Buy	80,743 +52,812	+189%	+$8.07M	0.54%	70
2022 Q4	$4.51M	Sell	27,931 -1,282	-4%	-$197K	0.19%	144
2022 Q3	$3.92M	Hold	29,213	–	–	0.17%	154
2022 Q2	$4.47M	Hold	29,213	–	–	0.19%	145
2022 Q1	$4.74M	Hold	29,213	–	–	0.16%	152
2021 Q4	$3.96M	Buy	29,213 +25	+0.1%	+$2.95K	0.12%	163
2021 Q3	$3.15M	Hold	29,188	–	–	0.1%	174
2021 Q2	$3.29M	Buy	29,188 +690	+2%	+$77.7K	0.1%	180
2021 Q1	$3.08M	Buy	28,498 +975	+4%	+$104K	0.1%	169
2020 Q4	$2.95M	Hold	27,523	–	–	0.1%	163
2020 Q3	$2.41M	Hold	27,523	–	–	0.11%	164
2020 Q2	$2.7M	Sell	27,523 -220	-0.8%	-$19.4K	0.13%	146
2020 Q1	$2.11M	Sell	27,743 -3,000	-10%	-$256K	0.14%	154
2019 Q4	$2.72M	Hold	30,743	–	–	0.13%	163
2019 Q3	$2.33M	Hold	30,743	–	–	0.12%	148
2019 Q2	$2.24M	Buy	30,743 +325	+1%	+$25.5K	0.12%	142
2019 Q1	$2.45M	Sell	30,418 -750	-2%	-$61.4K	0.14%	127
2018 Q4	$2.87M	Sell	31,168 -3,970	-11%	-$349K	0.21%	116
2018 Q3	$3.32M	Sell	35,138 -900	-2%	-$85.3K	0.19%	121
2018 Q2	$3.34M	Sell	36,038 -364	-1%	-$35.5K	0.21%	119
2018 Q1	$3.44M	Buy	36,402 +150	+0.4%	+$16.5K	0.23%	115
2017 Q4	$3.51M	Sell	36,252 -1,490	-4%	-$140K	0.22%	114
2017 Q3	$3.35M	Hold	37,742	–	–	0.21%	113
2017 Q2	$2.74M	Sell	37,742 -45	-0.1%	-$3.02K	0.18%	130
2017 Q1	$2.46M	Sell	37,787 -381	-1%	-$24K	0.17%	134
2016 Q4	$2.39M	Sell	38,168 -350	-0.9%	-$21.4K	0.18%	138
2016 Q3	$2.43M	Sell	38,518 -500	-1%	-$32.4K	0.18%	144
2016 Q2	$2.42M	Sell	39,018 -396	-1%	-$24.1K	0.19%	136
2016 Q1	$2.25M	Hold	39,414	–	–	0.2%	139
2015 Q4	$2.33M	Hold	39,414	–	–	0.21%	133
2015 Q3	$2.15M	Sell	39,414 -475	-1%	-$30.9K	0.21%	136
2015 Q2	$2.68M	Sell	39,889 -247	-0.6%	-$16.1K	0.25%	136
2015 Q1	$2.35M	Hold	40,136	–	–	0.2%	145
2014 Q4	$2.63M	Sell	40,136 -305	-0.8%	-$19.2K	0.3%	114
2014 Q3	$2.34M	Sell	40,441 -377	-0.9%	-$20.9K	0.32%	80
2014 Q2	$2.3M	Hold	40,818	–	–	0.33%	75
2014 Q1	$2.1M	Hold	40,818	–	–	0.33%	84
2013 Q4	$2.16M	Hold	40,818	–	–	0.33%	85
2013 Q3	$1.83M	Buy	40,818 +400	+1%	+$17.7K	0.3%	98
2013 Q2	$1.67M	Buy	+40,418	New	+$1.77M	0.3%	99

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Granite Investment Partners's ABBV Position: Q1 2026 in Review

Granite Investment Partners increased its AbbVie (ABBV) stake by 2.1% in Q1 2026, buying an estimated $224K and bringing the position to 47,914 shares worth $10.4M. The position accounts for 0.64% of the portfolio, ranked #48.

Granite Investment Partners first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.9M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Granite Investment Partners held 47,914 shares of AbbVie worth $10.4M as of Q1 2026.
Granite Investment Partners bought 1,008 AbbVie shares in Q1 2026, an estimated $224K.
AbbVie made up 0.64% of Granite Investment Partners's portfolio in Q1 2026, its #48 holding.
Granite Investment Partners first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Granite Investment Partners's AbbVie position peaked at $17.9M in Q3 2024.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.